Trial Profile
GW823093 Japan Phase IIa Mono
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Jul 2023
Price :
$35
*
At a glance
- Drugs Denagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline; GSK
- 20 Oct 2009 Planned end date (1 Oct 2007) added as reported by ClinicalTrials.gov.
- 15 Oct 2008 Actual start date changed from Apr 2006 to May 2006 as reported by ClinicalTrials.gov.
- 14 Oct 2008 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.